IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $506,000 | +226.5% | 82,830 | +242.2% | 0.00% | +100.0% |
| Q4 2022 | $155,000 | -45.6% | 24,206 | -18.5% | 0.00% | 0.0% |
| Q3 2022 | $285,000 | -77.9% | 29,700 | -61.7% | 0.00% | -80.0% |
| Q1 2022 | $1,290,000 | -15.8% | 77,463 | -3.5% | 0.01% | 0.0% |
| Q4 2021 | $1,532,000 | -24.5% | 80,249 | -2.4% | 0.01% | -28.6% |
| Q3 2021 | $2,028,000 | -6.0% | 82,220 | -0.8% | 0.01% | -12.5% |
| Q2 2021 | $2,157,000 | -6.9% | 82,887 | +13.3% | 0.01% | -11.1% |
| Q1 2021 | $2,317,000 | -26.2% | 73,175 | +8.1% | 0.01% | -35.7% |
| Q4 2020 | $3,141,000 | +74.5% | 67,700 | +23.8% | 0.01% | +40.0% |
| Q3 2020 | $1,800,000 | +27.1% | 54,673 | +6.0% | 0.01% | +25.0% |
| Q2 2020 | $1,416,000 | – | 51,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |